slides · global inventory
Paragraph
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 118,578
Current window 95,581-95,610
Pages 3,953
Rows per page 30
Component
95,581-95,610 of 118,578
11
The slide uses a personal/foundational anecdote to introduce a core business hypothesis.Recursion Pharmaceuticals | Investor Day Presentation Deck | 143 slides · Recursion Pharmaceuticals
Conference presentation Investor relations Beat · Agitate (Make it worse)Loop · Cost Of Inaction1 hit
26
Recursion Pharmaceuticals | Investor Day Presentation Deck | 143 slidesRecursion Pharmaceuticals | Investor Day Presentation Deck | 143 slides · Recursion Pharmaceuticals
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Jobs To Be Done1 hit
39
The slide uses a Venn-like overlapping pill shape to show how specific data modalities (Phenomics, Transcriptomics, etc.) feed into different stages of the drug discovery process.Recursion Pharmaceuticals | Investor Day Presentation Deck | 143 slides · Recursion Pharmaceuticals
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Jobs To Be Done1 hit
41
The slide uses a funnel-like progression visual to show how different technologies (Phenomics, Transcriptomics, InVivomics) integrate into the drug discovery process.Recursion Pharmaceuticals | Investor Day Presentation Deck | 143 slides · Recursion Pharmaceuticals
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Jobs To Be Done1 hit
47
Includes a process flow diagram at the top and specific performance metrics for chemical algorithms.Recursion Pharmaceuticals | Investor Day Presentation Deck | 143 slides · Recursion Pharmaceuticals
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Jobs To Be Done1 hit
48
The slide features a technical diagram of a DeBERTa-based architecture for chemistry and biology pre-training.Recursion Pharmaceuticals | Investor Day Presentation Deck | 143 slides · Recursion Pharmaceuticals
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Jobs To Be Done1 hit
49
The slide features a process flow diagram at the top right and a photo of the Biosero robotic system.Recursion Pharmaceuticals | Investor Day Presentation Deck | 143 slides · Recursion Pharmaceuticals
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Jobs To Be Done1 hit
50
Includes a process flow icon at the top right indicating the stage of the drug discovery pipeline.Recursion Pharmaceuticals | Investor Day Presentation Deck | 143 slides · Recursion Pharmaceuticals
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Jobs To Be Done1 hit
52
Recursion Pharmaceuticals | Investor Day Presentation Deck | 143 slidesRecursion Pharmaceuticals | Investor Day Presentation Deck | 143 slides · Recursion Pharmaceuticals
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Jobs To Be Done1 hit
57
The slide outlines a drug discovery workflow from target identification to preclinical validation.Recursion Pharmaceuticals | Investor Day Presentation Deck | 143 slides · Recursion Pharmaceuticals
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Jobs To Be Done1 hit
58
The slide uses a 'problem-solution' structure, contrasting the high unmet need in cancer patients (left) with the efficacy of the REC-0648918 compound in mouse models (right).Recursion Pharmaceuticals | Investor Day Presentation Deck | 143 slides · Recursion Pharmaceuticals
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Jobs To Be Done1 hit
60
The slide uses a problem-solution structure, contrasting market statistics with experimental cytokine data.Recursion Pharmaceuticals | Investor Day Presentation Deck | 143 slides · Recursion Pharmaceuticals
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Jobs To Be Done1 hit
68
The slide uses a decision tree/flowchart to segment patient populations by biomarker status and show corresponding mPFS outcomes.Recursion Pharmaceuticals | Investor Day Presentation Deck | 143 slides · Recursion Pharmaceuticals
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Jobs To Be Done1 hit
73
Recursion Pharmaceuticals | Investor Day Presentation Deck | 143 slidesRecursion Pharmaceuticals | Investor Day Presentation Deck | 143 slides · Recursion Pharmaceuticals
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Jobs To Be Done1 hit
74
Recursion Pharmaceuticals | Investor Day Presentation Deck | 143 slidesRecursion Pharmaceuticals | Investor Day Presentation Deck | 143 slides · Recursion Pharmaceuticals
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Jobs To Be Done1 hit
76
The slide contains three distinct chart types: a line chart for cell count impact, a statistical significance plot, and a grid of cosine similarity concentration response curves.Recursion Pharmaceuticals | Investor Day Presentation Deck | 143 slides · Recursion Pharmaceuticals
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Jobs To Be Done1 hit
80
Recursion Pharmaceuticals | Investor Day Presentation Deck | 143 slidesRecursion Pharmaceuticals | Investor Day Presentation Deck | 143 slides · Recursion Pharmaceuticals
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Jobs To Be Done1 hit
82
The chart uses a horizontal bar format to represent the stage of development for various oncology and rare disease programs.Recursion Pharmaceuticals | Investor Day Presentation Deck | 143 slides · Recursion Pharmaceuticals
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Jobs To Be Done1 hit
91
The slide contrasts human perception (Simvastatin looks like a rescue) with machine learning results (Cholecalciferol and REC-994 show rescue).Recursion Pharmaceuticals | Investor Day Presentation Deck | 143 slides · Recursion Pharmaceuticals
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Jobs To Be Done1 hit
94
The table compares Placebo against 50mg, 200mg, 400mg, and 800mg doses across various safety metrics.Recursion Pharmaceuticals | Investor Day Presentation Deck | 143 slides · Recursion Pharmaceuticals
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Jobs To Be Done1 hit
95
The slide outlines a randomized controlled trial structure with three arms (400mg, 200mg, placebo) followed by a 12-month treatment period.Recursion Pharmaceuticals | Investor Day Presentation Deck | 143 slides · Recursion Pharmaceuticals
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Jobs To Be Done1 hit
98
The slide uses a pie chart to segment the patient population and an MRI scan to illustrate the clinical problem.Recursion Pharmaceuticals | Investor Day Presentation Deck | 143 slides · Recursion Pharmaceuticals
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Jobs To Be Done1 hit
100
The slide uses a numbered process flow to explain the mechanism of action of a drug candidate.Recursion Pharmaceuticals | Investor Day Presentation Deck | 143 slides · Recursion Pharmaceuticals
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Jobs To Be Done1 hit
101
The slide uses a split-screen layout to compare two different preclinical efficacy studies.Recursion Pharmaceuticals | Investor Day Presentation Deck | 143 slides · Recursion Pharmaceuticals
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Jobs To Be Done1 hit
111
Clinical: FAP context. Slide 111.Recursion Pharmaceuticals | Investor Day Presentation Deck | 143 slides · Recursion Pharmaceuticals
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Jobs To Be Done1 hit
116
The slide uses a heatmap to demonstrate biological similarity between drug dosage effects and specific gene regulation.Recursion Pharmaceuticals | Investor Day Presentation Deck | 143 slides · Recursion Pharmaceuticals
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Jobs To Be Done1 hit
117
The slide compares efficacy in mutant vs wildtype models using bar charts for tumor growth inhibition and Kaplan-Meier curves for progression-free survival.Recursion Pharmaceuticals | Investor Day Presentation Deck | 143 slides · Recursion Pharmaceuticals
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Jobs To Be Done1 hit
01
Signature Bank | Results Presentation Deck | 30 slidesSignature Bank | Results Presentation Deck | 30 slides · Signature Bank
Conference presentation Investor relations Beat · Attention1 hit
12
The slide includes a footnote regarding non-GAAP financial measures.Signature Bank | Results Presentation Deck | 30 slides · Signature Bank
Conference presentation Investor relations Beat · Satisfaction1 hit
28
Includes annotations for specific financial impacts like Taxi Medallion charge-offs, COVID-19/CECL impact, and AOCI.Signature Bank | Results Presentation Deck | 30 slides · Signature Bank
Conference presentation Investor relations Beat · Action1 hit